版本:
中国

BRIEF-Orexigen Therapeutics on March 28, 2017, entered into controlled equity offering sales agreement

March 30 Orexigen Therapeutics Inc

* Orexigen Therapeutics Inc- on March 28, 2017, entered into a controlled equity offering sales agreement - sec filing

* Orexigen Therapeutics -under deal co may offer and sell, through agent, shares par value $0.001 per share, with aggregate offering price up to $20 million Source text (bit.ly/2nEXTF7) Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐